Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kianzad (Amsterdam, Netherlands), F. De Man (Amsterdam, Netherlands), L. Celant (Amsterdam, Netherlands), A. Vonk Noordegraaf (Amsterdam, Netherlands), L. Handoko (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands). Precapillary pulmonary hypertension in patients with a high HFpEF probability: Insights from the Amsterdam UMC PAH-cohort. 1516

Member's Comments

No comment yet.

Related content which might interest you: Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Cancer incidence in incident patients with precapillary pulmonary hypertension. Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Pulmonary artery to aorta ratio and mortality risk in the general population: The Rotterdam study Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Comparison pulmonary rehabilitation efficiency in COPD patients between with and without pulmonary hypertension Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 Right heart catheterization in elderly patients with suspected pre-capillary pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Myocardial perfusion in patients with pulmonary hypertension of different etiology Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Registries for paediatric pulmonary hypertension Source: Eur Respir J 2013; 42: 580-583 Year: 2013 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH) Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012 Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Afterload reduction governs improvement in RV systolic function and ventriculo-arterial adaptation in patients with pulmonary arterial hypertension (PAH) undergoing rapid dose escalation of treprostinil Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Assessment of pulmonary hypertension in patients over 70 Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 Endothelial dysfunction in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 589-596 Year: 2012